Your browser doesn't support javascript.
loading
Targeting the nucleolus for cancer-specific activation of p53.
Drygin, Denis; O'Brien, Sean E; Hannan, Ross D; McArthur, Grant A; Von Hoff, Daniel D.
Affiliation
  • Drygin D; Cylene Pharmaceuticals, 5935 Cornerstone Court West #100, San Diego, CA 92121, USA.
  • O'Brien SE; Senhwa Bioscience, 9191 Towne Centre Drive, San Diego, CA 92122, USA.
  • Hannan RD; Division of Cancer Research, Peter MacCallum Cancer Centre, Locked Bag 1, Melbourne, 8006 Victoria, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010 Victoria, Australia; Department of Biochemistry and Cell Biology, The University of Melbourne, Parkv
  • McArthur GA; Division of Cancer Research, Peter MacCallum Cancer Centre, Locked Bag 1, Melbourne, 8006 Victoria, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010 Victoria, Australia.
  • Von Hoff DD; The Translational Genomics Research Institute, 445 N. Fifth Street, Phoenix, AZ 85004, USA. Electronic address: dvh@tgen.org.
Drug Discov Today ; 19(3): 259-65, 2014 Mar.
Article in En | MEDLINE | ID: mdl-23993916
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tumor Suppressor Protein p53 / Neoplasms / Antineoplastic Agents Limits: Animals / Humans Language: En Journal: Drug Discov Today Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2014 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tumor Suppressor Protein p53 / Neoplasms / Antineoplastic Agents Limits: Animals / Humans Language: En Journal: Drug Discov Today Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2014 Type: Article Affiliation country: United States